The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

Table 1 Utility weights of relevant health states

State	Expected value	SE	95% CI	Source
During AS	0.99	0.05	1; 0.9	Bremner [28], Liu [33], own calculation
Urinary difficulty during AS	0.89	0.024	0.91; 0.85	Steward 2005
During PE treatment	0.67	0.041	0.75; 0.59	Steward 2005
During radiotherapy	0.73	0.045	0.82; 0.64	Steward 2005
Post treatment no adverse effects	0.99	0.05	1; 0.9	Bremner [28], Liu [33], own calculation
Post treatment IC	0.83	0.022	0.87; 0.79	Steward 2005
Post treatment ED	0.89	0.013	0.92; 0.86	Steward 2005
Post treatment BP	0.71	0.021	0.75; 0.67	Steward 2005
Post treatment IC, ED	0.79	0.033	0.86; 0.72	Steward 2005
Post treatment IC, BP	0.70	0.036	0.77; 0.63	Steward 2005
Post treatment ED, BP	0.57	0.039	0.65; 0.49	Steward 2005
Post treatment IC, ED, BP	0.45	0.044	0.54; 0.36	Steward 2005
Metastatic disease	0.25	0.015	0.28; 0.22	Steward 2005

ISSN: 1472-6963